ES8800275A1 - Procedimiento para la preparacion de nuevos antigenos nativos pseudomonas-flagella (h) - Google Patents
Procedimiento para la preparacion de nuevos antigenos nativos pseudomonas-flagella (h)Info
- Publication number
- ES8800275A1 ES8800275A1 ES550831A ES550831A ES8800275A1 ES 8800275 A1 ES8800275 A1 ES 8800275A1 ES 550831 A ES550831 A ES 550831A ES 550831 A ES550831 A ES 550831A ES 8800275 A1 ES8800275 A1 ES 8800275A1
- Authority
- ES
- Spain
- Prior art keywords
- antigens
- flagellar
- pct
- fag
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE ANTIGENOS NATIVOS PSEUDOMONAS-FLAGELLA (H). CONSISTE EN TRATAR CULTIVOS DE BACTERIAS PSEUDOMONAS AERUGINOSA, O FRACCIONES DE LOS MISMOS, CON UN DETERGENTE TAL COMO UNA SAL DEL ACIDO BILIAR, EN ESPECIAL CON OXICOLATO, PREPARACION DE LOS ANTIGENOS NATIVOS, POLIDISERSOS, DE LOS CULTIVOS; SEPARACION PREVIA DE BACTERIAS Y PARTICULAS DE BACTERIAS MEDIANTE CENTRIFUGACION; Y DEPURACION MEDIANTE TRATAMIENTO CROMATOGRAFICO. ESTOS ANTIGENOS TIENEN APLICACIONES FARMACOLOGICAS EN METODOS INMUNOLOGICOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0007285A AT384032B (de) | 1985-01-14 | 1985-01-14 | Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag) |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8800275A1 true ES8800275A1 (es) | 1987-11-01 |
ES550831A0 ES550831A0 (es) | 1987-11-01 |
Family
ID=3480790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES550831A Expired ES8800275A1 (es) | 1985-01-14 | 1986-01-13 | Procedimiento para la preparacion de nuevos antigenos nativos pseudomonas-flagella (h) |
Country Status (10)
Country | Link |
---|---|
US (1) | US4831121A (es) |
EP (1) | EP0208743B1 (es) |
JP (1) | JPH085801B2 (es) |
AT (2) | AT384032B (es) |
CA (1) | CA1263307A (es) |
DE (1) | DE3686961D1 (es) |
DK (1) | DK172329B1 (es) |
ES (1) | ES8800275A1 (es) |
FI (1) | FI85221C (es) |
WO (1) | WO1986003974A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5237053A (en) * | 1986-06-24 | 1993-08-17 | Immuno Aktiengesellschaft | Preparation active against Pseudomonas aeruginosa infections and methods of producing them |
AT391080B (de) * | 1986-06-24 | 1990-08-10 | Immuno Ag | Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen |
AT390192B (de) * | 1988-08-29 | 1990-03-26 | Immuno Ag | Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen |
US4994161A (en) * | 1989-02-02 | 1991-02-19 | University Of New Hampshire | Apparatus and method for macromolecular charge determination |
EP1753464A2 (en) * | 2004-03-26 | 2007-02-21 | Quark Biotech, Inc. | Annexin ii and uses thereof |
WO2009033013A1 (en) * | 2007-09-05 | 2009-03-12 | Nurit Rachamim | Antibodies against flagellin and uses thereof |
US20100239583A1 (en) * | 2009-03-04 | 2010-09-23 | Inotek Pharmaceuticals Corporation | Antibodies against flagellin and uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3928565A (en) * | 1971-10-19 | 1975-12-23 | Yuzuru Homma | Pharmaceutical preparation of pseudomonas aeruginosa bacterial component possessing anti-tumor and anti-infection properties |
JPS51133489A (en) * | 1975-05-14 | 1976-11-19 | Tokyo Daigaku | Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities |
FR2460139A1 (fr) * | 1979-06-29 | 1981-01-23 | Pasteur Institut | Fraction antigenique glycopeptidique vaccinante a tres grande immunogenicite isolee de cultures de germes pathogenes, procedes d'isolement de cette fraction et vaccins contenant ladite fraction |
US4271147A (en) * | 1980-01-10 | 1981-06-02 | Behringwerke Aktiengesellschaft | Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same |
EP0048422A3 (en) * | 1980-09-15 | 1983-08-24 | Bactex Incorporated | Pili of pseudomonas aeruginosa and utilization of same as vaccines against infectionary p.aeruginosa |
US4470924A (en) * | 1981-12-30 | 1984-09-11 | Iglewski Barbara M | Nontoxic, immunologically crossreactive toxin A protein from Pseudomonas aeruginosa |
US4578458A (en) * | 1983-03-23 | 1986-03-25 | Brigham And Women's Hospital | Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa |
-
1985
- 1985-01-14 AT AT0007285A patent/AT384032B/de not_active IP Right Cessation
-
1986
- 1986-01-13 DE DE8686900707T patent/DE3686961D1/de not_active Expired - Fee Related
- 1986-01-13 AT AT86900707T patent/ATE81471T1/de not_active IP Right Cessation
- 1986-01-13 JP JP61500683A patent/JPH085801B2/ja not_active Expired - Fee Related
- 1986-01-13 EP EP86900707A patent/EP0208743B1/de not_active Expired - Lifetime
- 1986-01-13 US US06/912,242 patent/US4831121A/en not_active Expired - Lifetime
- 1986-01-13 CA CA000499444A patent/CA1263307A/en not_active Expired
- 1986-01-13 ES ES550831A patent/ES8800275A1/es not_active Expired
- 1986-01-13 WO PCT/AT1986/000002 patent/WO1986003974A1/de active IP Right Grant
- 1986-09-03 DK DK421486A patent/DK172329B1/da not_active IP Right Cessation
- 1986-09-11 FI FI863677A patent/FI85221C/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US4831121A (en) | 1989-05-16 |
JPH085801B2 (ja) | 1996-01-24 |
JPS62501363A (ja) | 1987-06-04 |
ATE81471T1 (de) | 1992-10-15 |
DK172329B1 (da) | 1998-03-23 |
DE3686961D1 (de) | 1992-11-19 |
EP0208743B1 (de) | 1992-10-14 |
DK421486D0 (da) | 1986-09-03 |
EP0208743A1 (de) | 1987-01-21 |
ATA7285A (de) | 1987-02-15 |
FI85221B (fi) | 1991-12-13 |
CA1263307C (en) | 1989-11-28 |
FI863677A (fi) | 1986-09-11 |
FI85221C (fi) | 1992-03-25 |
DK421486A (da) | 1986-09-03 |
AT384032B (de) | 1987-09-25 |
ES550831A0 (es) | 1987-11-01 |
CA1263307A (en) | 1989-11-28 |
FI863677A0 (fi) | 1986-09-11 |
WO1986003974A1 (en) | 1986-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Farrar et al. | Biochemical relationship of thymocyte mitogenic factor and factors enhancing humoral and cell-mediated immune responses | |
ES2071706T3 (es) | Metodo para fraccionar proteinas plasmaticas. | |
ES8103976A1 (es) | Un metodo de producir proteinas de interferon humano de for-ma le | |
AU533386B2 (en) | Isolation of membrane proteins from neisseria meningitidis and vaccines containing same | |
DK170186D0 (da) | Biologisk ren kultur af en stamme lactobacillus acidophilus samt fremgangsmaade til isolering af en saadan kultur og anvendelse af denne somlaegemiddel | |
DE69032806T2 (de) | Verfahren zur isolierung und reinigung von rezeptoren für transferrin und lactoferrin von bakterien und herstellung von impfstoffen, die sie enthalten | |
ATE170630T1 (de) | Proteine mit geänderten epitopen und verfahren zur deren herstellung | |
AU6733487A (en) | Mammalian interleukin-4 | |
ATE113654T1 (de) | Follistatin und verfahren zur reinigung desselben. | |
Mond et al. | Affinity-purified interleukin 2 induces proliferation of large but not small B cells. | |
DE3686954D1 (de) | Loeslichkeits-, reinigungs- und charakterisierungsverfahren fuer proteine aus unloeslichen proteinaggregaten oder proteinkomplexen und diesbezuegliche praeparate. | |
JPS5782322A (en) | Novel immunostimulant sugar protein extracted from pneumonia bacillus,obtaining method, application as drug and composition containing same | |
ES8609360A1 (es) | Procedimiento para preparar peptidos | |
ES8800275A1 (es) | Procedimiento para la preparacion de nuevos antigenos nativos pseudomonas-flagella (h) | |
DE3585713D1 (de) | Immunoverstaerker und verfahren zu ihrer herstellung. | |
EP0249412A3 (en) | C-terminal alpha-amidating enzyme and process for production and use thereof | |
EP0536564B1 (de) | Verfahren zur Reinigung von Streptolysin 0, intaktes Streptolysin 0 erhältlich nach diesem Verfahren und seine Verwendung | |
DE3882154T2 (de) | Verfahren zur Herstellung des pres 1/S2/S-Hepatitis-B-Antigens aus Hefe. | |
Postlethwaite et al. | Latent lymphokines: isolation of guinea pig latent lymphocyte-derived chemotactic factor for monocytes. Its activation by trypsin and a soluble factor from macrophages | |
TAYLOR et al. | Markedly enhanced production of gamma interferon in murine T lymphocytes treated with lentil lectin and the diterpene ester, mezerein | |
HENSTEN‐FETTERSEN et al. | Human salivary alpha‐amylase Purification and amino acid composition | |
IL72986A (en) | Production of intact recombinant human immune interferon essentially free of proteolytic fragments thereof and pharmaceutical compositions containing such an interferon | |
JPS5767591A (en) | Protein element substance and its preparation | |
FR2559157B1 (fr) | Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent | |
Watanabe et al. | Homology of partial primary sequences between α-enolase and a suppressive lymphokine from human T cells |